- The FDA approves GlaxoSmithKline's (NYSE:GSK +0.1%) allergy spray Flonase (fluticasone propionate 50 mcg) for sale over-the-counter as a treatment for temporary relief of symptoms of hay fever or upper respiratory allergies. The product will be available in stores in early 2015.